DOPATREE
Preview
Open in TheBrain
DOPATREE
ORGANIZATIONS
COMPANIES-ALL (COMPANY, CLIENTS, SPONSORS, SMALL, MID-SIZE, LARGE PHARMA, BIG PHARMA, BIOPHARMA, EMERGING COMPANIES, STARTUPS, START-UPS, SPIN-OFFS, SUBSIDIARIES, SUBSIDIARY, BIOTECHNOLOGY, EMERGING)
COMPANIES / LISTINGS-A
ABBVIE
ABBVIE / PRODUCTS / APPROVED
HUMIRA® (ADALIMUMAB)
HUMIRA / MARKET ACCESS
Parents
HUMIRA® (ADALIMUMAB)
Children
ICER. PSORIASIS. AN ASSESSMENT OF ANTI TNF AGENTS, ANTI IL-17A AGENTS, ANTI IL-12/23 AGENTS, AND AN ANTI PDE4 AGENT. PUBLIC MTG. NOV 2016.
ICER. RHEUMATOID ARTHRITIS. A CLASS REVIEW OF TNF INHIBITORS, CD20-DIRECTED CYTOLYTIC ANTIBODIES, T-CELL INHIBITORS, IL-6 INHIBITORS, AND JAK INHIBITORS. PUBLIC MEETING. MAR 2017.
ICER. RHEUMATOID ARTHRITIS. AN ASSESSMENT OF JAK INHIBITORS. PUBLIC MEETING. DEC 2019.
ICER. ULCERATIVE COLITIS. AN ASSESSMENT OF TREATMENTS FOR ULCERATIVE COLITIS. PUBLIC MEETING. SEP 2020.